Nuzenio

Lifemine Ceo Verdine

Lifemine Ceo Verdine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 13:09:00 GMTLifeMine CEO Verdine Raises $263M From Bezos and Gates to Replace Tacrolimus, the Transplant Drug That Destroys Kidneys - finance.biggo.com
Thu, 06 Aug 2026 10:31:57 GMTBezos, Gates back LifeMine's transplant aspirations in $263M raise - FirstWord Pharma
Thu, 06 Aug 2026 10:30:00 GMT‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E - Fierce Biotech
Thu, 06 Aug 2026 10:30:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints News
Thu, 06 Aug 2026 10:30:00 GMTLifeMine Therapeutics raises $263M; investors include Bezos, Gates funds - The Business Journals

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lifemine Ceo Verdine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.